Deletion Variants within the NF-kB Activation Domain of the LMP1 Oncogene in Acquired Immunodeficiency Syndrome-Related Large Cell Lymphomas, in Prelymphomas and Atypical Lymphoproliferations

References

• Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 1968; 59: 94–101
   PubMed Web of Science ®Google Scholar
• Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 702–703
   PubMed Web of Science ®Google Scholar
• Fahraeus R., Fu H.L., Ernberg I., Finke J., Rowe M., Klein G., Falk K., Nilsson E., Yaday M., Busson P., Tursz T., Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 1988; 42: 329–338
   PubMed Web of Science ®Google Scholar
• Brousset P., Butet V., Chittal S., Selves J., Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab. Invest. 1992; 67: 457–464
   PubMed Web of Science ®Google Scholar
• Crawford D.H., Thomas J.A., Janossy G., Sweny P., Fernando O.N., Moorhead J.F., Thompson J.H. Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin a treatment in patient with renal allograft. Lancet 1980; 1355–1356
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S.J., Rea D., Raphael M., Sandvej K., Delecluse H.J., Gisselbrecht G., Marelle L., van Krieken J. H. H. M., Pallesen G. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related Non-Hodgkin's lymphoma. Blood 1993; 82: 619–624
   PubMed Web of Science ®Google Scholar
• Weiss L.M., Movahed L.A., Warnke R.A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Knecht H., Sahli R., Shaw P., Meyer C., Bachmann E., Odermatt B.F. Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br. J. Haematol. 1990; 75: 610–614
   PubMed Web of Science ®Google Scholar
• Bankier A.T., Deininger P.L., Satchwell S.C., Baer R., Farrell P.J., Barrell G.B. DNA sequence analysis of the EcoR1 Dhet fragment of B95–8 Epstein-Barr virus containing the terminal repeat sequences. Mol. Biol, Med. 1983; 1: 425–145
   PubMedGoogle Scholar
• Fennewald S., van Santen V., Kieff E. Nucleotide sequence of a mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol 1984; 51: 411–419
   PubMed Web of Science ®Google Scholar
• Hennessy K., Fennewald S., Hummel M., Cole T., Kieff E. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. Natl. Acad. Sci. USA 1984; 81: 7207–7211
   PubMed Web of Science ®Google Scholar
• Deacon E.M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A.B., Young L.S. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in malignant cells. J. Exp. Med. 1993; 177: 339–349
   PubMed Web of Science ®Google Scholar
• Chen F., Hu L.F., Ernberg I., Klein G., Winberg G. Coupled transcription of Epstein-Barr virus latent memhrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J. Gen. Virol. 1995; 76: 131–138
   PubMed Web of Science ®Google Scholar
• Tierney R.J., Steven N., Young L.S., Rickinson A.B. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 1994; 68: 7374–7385
   PubMed Web of Science ®Google Scholar
• Thomas J.A., Hotchin N.A., Allday M.J., Amlot P., Rose M., Yacoub M., Crawford D.H. Immunohistology of Epstein-Baar virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 1990; 49: 944–953
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms estahlished rodent cells. Cell 1988; 43: 831–840
   Web of Science ®Google Scholar
• Fuhraeus R., Rymo L., Rhim J.S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 437–449
   PubMed Web of Science ®Google Scholar
• Dawson C.W., Rickinson A.B., Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344: 777–780
   PubMed Web of Science ®Google Scholar
• Peng M., Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellulat- activation and DNA synthesis. Oncogene 1992; 7: 1775–1782
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Lonpnecker R., Kieff E., Rickinson A. Induction or bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Mosialos G., Birkenbach M., Yalamanchili R., Van Arsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 380–399
   Web of Science ®Google Scholar
• Mitchell T., Sugden R. Stimulation of NF-kB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 1995; 69: 2068–2976
   PubMedGoogle Scholar
• Huen D.S., Henderson S.A., Croon-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Ontogene 1995; 10: 549–560
   Google Scholar
• Herrero J.A., Mathew P., Paya C.V. LMP-1 activates NP-kB by targeting the inhibitory molecule IkBα. J. Virol. 1095; 69: 2168–2174
   Google Scholar
• Baeuerle P.A., Henkel T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 1994; 12: 141–179
   PubMed Web of Science ®Google Scholar
• Hu L.F., Zabarovsky E.R., Chen F., Cao S.F., Ernberg I., Klein G., Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 1991; 72: 2399–2400
   PubMed Web of Science ®Google Scholar
• Chang Y.S., Su I.J., Chung P.J., Shu C.H., Ng C.K., Wu S.J., Liu S.T. Detection ot en Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanes population. Int. J. Cancer 1995; 62: 673–677
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., Sandvej K., Nadal D., Bachmann F., Odermatt B.F., Delsol G., Pallesen G. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Joske D. J. L., Sahli R., Emery-Goodman A., Casanova J.L., Zilic M., Bachmann F., Odermatt B.F. Molecular anaylsis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993; 7: 580–585
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., Rothenberger S., Einsele If., Lestou V.S., Delsol C., Bachmann F., Ambros P.F., Odermatt R.F. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995; 10: 523–528
   PubMed Web of Science ®Google Scholar
• Santon A., Manzanal A.I., Campo E., Bellas C. Deletions in the Epstein-Barr virus latent membrane prtrtein- 1 oncogene in Hodgkin's disease. J. Clin. Pathol.: Mol. Pathol. 1995; 48: M184–M187
   Web of Science ®Google Scholar
• Knecht H., Raphael M., McQuain C., Kothenberger S., Pihan G., Bachmann E., Ryan S., Kittler E. L. W., Quesenberry P.J., Schlaifer D., Woda B.A., Brousset P. Deletion variants within the NF-kB activation domain of the LMP1 oncogene prevail in AIDS-related large cell lymphomas and HIV-negative atypical lymphoproliferations. Blood 1996; 87: 876–881
   PubMed Web of Science ®Google Scholar
• Palefsky J.M., Berline J., Penarandu M.E., Lennette E.T., Greenspan D., Greenspan J.S. Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia. J. Infect. Dis. 1996; 173: 710–714
   PubMed Web of Science ®Google Scholar
• Walling D.M., Clark N.M., Markovitz D.M., Frank T.S., Braun D.K., Eisenberg E., Krutchkoff D.J., Felix D.H., Raab-Traub N. Epstein-Barr cirus coinfection and recombination in non-human immunodeficiency virus association. ated oral hairy leukoplakia. J. Infect. Dis. 1995; 171: 1122–1130
   PubMed Web of Science ®Google Scholar
• Berger C., McQuain C., Sullivan J., Nadal D., Quesenberry P.J., Knecht H. The LMP1 30 base pair deletion variant with enhanced oncogenic activity prevails in acute infectious mononucleosis and EBV-associated tonsillar hyperplasia. Blood 1996, Abstr. (in press)
   Web of Science ®Google Scholar
• Knecht H., McQuain C., Martin J., Drexler H.G., Rothenberger S., Berger C., Bachmann E., Kittler E. L. W., Odermati B.F., Quesenberry P.J. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene 1996; 13: 947–953
   PubMed Web of Science ®Google Scholar
• Li S.N., Chang Y.S., Liu S.T. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996; 12: 2129–2135
   PubMed Web of Science ®Google Scholar
• Sandvej K., Peh S.C., Andresen B.S., Pallesen G. Identification of potential hot spots in the carboxy-termind part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053–4060
   PubMed Web of Science ®Google Scholar
• Vasef M.A., Kamel O.W., Chen Y.Y., Medeiros J., Weiss L.M., Abbot S.D. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am. J. Pathol. 1995; 147: 1408–1415
   PubMed Web of Science ®Google Scholar
• Kingma D.W., Weiss W.B., Jaffe E.S., Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Chen W.C., Chen Y.Y., Bacchi M.M., Bacchi C.E., Alvarenga M. W. L. M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Am. J. Pathol. 1996; 148: 17–23
   PubMed Web of Science ®Google Scholar
• Brousset P., Schlaifer D., Meggetto F., Bachmann E., Rothenberger S., Delsol G., Knecht H. Persistance of the same viral strain in early and late relapses of Epstein-Barr virus associated Hodgkin's disease. Blood 1994; 84: 2441–2451
   Google Scholar
• Knecht H., Martius F., Bachmann E., Hoffmann T., Zimmermann D.R., Rothenberger S., Sandvej K., Wegmann W., Hurwitz N., Odermatt B.F., Kummer H., Pallesen G. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with transformation of angioimmunoblastic lymphadenopathy into B-immunoblastic lymphoma. Leukemia 1995; 9: 458–465
   PubMed Web of Science ®Google Scholar
• Kershaw G.R., McQuain C., Berger C., Pihan G., Odermatt B.F., Quesenberry P.J., Woda B.A., Knecht H. Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a LMP1 deletion variant. 1996, (Submitted)
   Google Scholar
• Klein C., Rothenberger S., Niemeyer C., Bachmann E., Odermatt B., Boehm N., Brandis M., Knecht H. EBV-associated lymphoproliferative syndrome with a distinct 69 hase-pair deletion in the LMP-1 oncogene. Br. J. Haematol. 1995; 91: 938–940
   PubMed Web of Science ®Google Scholar
• Larcher C., McQuain C., Berger C., Mitterer M., Huemer H.P., Quesenberry P.J., Knecht H. Epstein-Barr virus associated persistent polyclonal B-cell lymphocytosis with a distinct 69 base pair deletion in the LMP-1 oncogene. Ann. Haematol. 1996, (in press)
   Web of Science ®Google Scholar
• Grunewald V., Bonnet M., Martel Renoir D., Cochet C., Joab I. Heterogeneity within the Epstein-Barr virus transactivator, zebra, derived from nasopharyngeal carcinoma. Epstein-Barr Virus & Associated Diseases 1994; 208, (Abstract)
   Google Scholar
• Chen M.L., Tsai C.N., Liang C.L., Shu C.H., Hang C.R., Sulitzeanu D., Liu S.T., Chang Y.S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131–2140
   PubMed Web of Science ®Google Scholar
• Trivedi P., Hu L.F., Chen F., Christensson B., Masucci M.G., Klein G., Winberg G. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contract to a B cell-derived homologue. Eur. J. Cancer 1994; 30A: 84–88
   PubMed Web of Science ®Google Scholar
• Hu L.F., Chen F., Zheng X., Ernberg I., Cao S.L., Christensson B., Klein G., Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993; 8: 1575–1583
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S.J., Rowe M., Young L.S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; i: 320–322
   Web of Science ®Google Scholar
• Herbst H., Dallenhach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Hammarskjold M.L., Simurada M.C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kB activity. J. Virol. 1992; 66: 6496–6501
   PubMed Web of Science ®Google Scholar
• Laherty C.D., Hu H.M., Opipari A.W., Wang F., Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J. Biol. Chem. 1992; 267: 24157–24160
   PubMed Web of Science ®Google Scholar
• Rothenberger S., Bachmann E., Knecht H. Natural 30 bp and 69 bp deletion variants of the LMP1 oncogene do stimulate NK-kB-mediated transcription. Oncogene 1996, (manuscript in revision)
   PubMed Web of Science ®Google Scholar
• Van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J. A. M., Johnson R.P., van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate-and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J. Biol. Chem. 1994; 269: 6185–6192
   PubMed Web of Science ®Google Scholar
• Martin J., Sugden B. Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J. Virol. 1991; 65: 3246–3258
   PubMed Web of Science ®Google Scholar
• Liu Y.-J., Joshua D.E., Williams G.T., Smith C.A., Gordon J., MacLennan I. C. M. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Liu Y.J., Malisan F., de Bouteiller O., Guret C., Lebecque S., Banchereau J., Mills F.C., Max E.E., Martinez-Valdez H. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996; 4: 241–250
   PubMed Web of Science ®Google Scholar
• Carbone A., Tirelli U., Gloghini A., Volpe R., Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may he subdivided into two main groups according to Epstein-Barr viral latent gene expression. J. Clin. Oncol. 1993; 11: 1674–1681
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S.J., Raphael M., Audouin J., Diebold J., Lisse I., Pedersen C., Oksenhendler E., Marelle L., Pallesen G. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 82: 69–624
   Google Scholar
• Moorthy R.K., Thorley-Lawson D.A. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. J. Virol. 1993; 67: 1638–1646
   PubMed Web of Science ®Google Scholar
• Seto E., Benedict Yen T.S., Matija Peterlin B., Ou J.-H. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA 1988; 85: 8286–8290
   PubMed Web of Science ®Google Scholar
• Sun S.-C., Elwood J., Beraud C., Greene W.C. Human T-cell leukemia virus type 1 tax activation of NF-kB/Rel involves phosphorylation and degradation of IkBα and RelA (p65)-mediated induction of the c-rel gene. Mol. & Cell. Biol. 1994; 14: 7377–7384
   Web of Science ®Google Scholar
• Kanno T., Franzoso G., Siebenlist U. Human T-cell leukemia virus type 1 Tax-protein-mediated activation of NF-kB from p100 (NF-kB2)-inhibited cytoplasmic reservoirs. Proc. Natl. Acad. Sci USA 1994; 91: 12634–12638
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Brach M.A., Drexler H.G., Bonifer R., Mertelsmann R.H. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res. 1992; 52: 3353–3360
   PubMed Web of Science ®Google Scholar
• Bargou R.C., Leng C., Krappmann D., Emmerich F., Mapara M.K., Bommert K., Royer H.D., Scheidereit C., Doerken B. High-level nuclear NF-kB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340–4347
   PubMed Web of Science ®Google Scholar
• Gruss H.J., Ulrich D., Dower S.K., Herrtmann F., Brach M.A. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kB transcription factor. Blood 1996; 87: 2443–2449
   PubMed Web of Science ®Google Scholar
• Baker S.J., Reddy E.P. Transducers of life nnd death: TNF receptor superfamily and associated proteins. Oncogene. 1996; 12: 1–9
   PubMed Web of Science ®Google Scholar